ArticleFrontiers in immunology2024

Efficacy and safety of neoadjuvant chemoimmunotherapy and chemotherapy in patients with potentially resectable stage IIIA/IIIB NSCLC: a retrospective study.

Yuchen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.